JACOBS LEVY EQUITY MANAGEMENT, INC - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 89 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q3 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.0%.

Quarter-by-quarter ownership
JACOBS LEVY EQUITY MANAGEMENT, INC ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q3 2021$117,000
-88.1%
114,466
-2.7%
0.00%
-90.9%
Q2 2020$987,000
+356.9%
117,608
+185.5%
0.01%
+266.7%
Q1 2020$216,00041,1980.00%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q3 2021
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$5,147,0002.57%
ETF MANAGERS GROUP, LLC 14,101,511$14,243,0000.27%
Ikarian Capital, LLC 948,526$968,0000.07%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 289,627$295,0000.04%
Platform Technology Partners 60,000$61,0000.03%
PINNACLE ASSOCIATES LTD 966,014$985,0000.02%
XTX Topco Ltd 41,599$42,0000.01%
Virtu Financial LLC 160,380$164,0000.01%
Tekla Capital Management LLC 413,481$422,0000.01%
Aries Wealth Management 23,400$24,0000.01%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders